Y-MABS
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 18 Aug 2024)
What this means for you
Registered since 15 Jan 2019. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87676483
- Registration number
- 5652645
- Mark type
- Stylized text
- Filed
- 08 Nov 2017
- Published for opposition
- 30 Oct 2018
- Registered
- 15 Jan 2019
- Attorney of record
- Andrew N. Spivak
Goods and services
- Class 042 — Scientific and technological services: Research and development services in the field of antibodies; research and development services in the field of antibody technology; laboratory research and analysis services relating to the production of antibodies; scientific and technological services, namely, scientific research, analysis, and testing in the field of antibodies, and research and design relating thereto; industrial analysis and research services in the field of antibodies
Owner
- Y-mAbs Therapeutics, Inc., New York, NY, US
- Y-mAbs Therapeutics, Inc., New York, NY, US
- Y-mAbs Therapeutics, Inc., New York, NY, US
Prosecution history
- 18 Aug 2024 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 18 Aug 2024 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 18 Aug 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 01 Feb 2024 — TEAS SECTION 8 & 15 RECEIVED
- 15 Jan 2024 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 15 Jan 2019 — REGISTERED-PRINCIPAL REGISTER
- 30 Oct 2018 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 30 Oct 2018 — PUBLISHED FOR OPPOSITION
- 10 Oct 2018 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 23 Sept 2018 — ASSIGNED TO LIE
- 08 Sept 2018 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 18 Aug 2018 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 17 Aug 2018 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 17 Aug 2018 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 25 Feb 2018 — NOTIFICATION OF NON-FINAL ACTION E-MAILED